Evidence Connections

Follow the evidence beyond the paper.

Follow source-linked research projects, organizations, FDA application actions, compound targets and genetic studies.

Explore relationships stated by the original sources. Each number opens its exact collection—not a count of extra papers or proven treatments.

Research ↔ organizationOctober 15, 2025

Development of Age‐ and Sex‐Specific Metabolomics‐Based Biological Ageing Clocks for 10‐Year Mortality Prediction

Organization linked by OpenAIRE · German Cancer Research Center

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
FDA application actionOctober 15, 2025

liraglutide

Approved submission · SUPPL 3

A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.

Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

Chemotherapy accelerated bone ageing is reversed by NMN

Organization linked by OpenAIRE · Harvard University

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

Chemotherapy accelerated bone ageing is reversed by NMN

Organization linked by OpenAIRE · University of Queensland

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

Chemotherapy accelerated bone ageing is reversed by NMN

Organization linked by OpenAIRE · Royal Women's Hospital

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

Chemotherapy accelerated bone ageing is reversed by NMN

Organization linked by OpenAIRE · UNSW Sydney

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

Cellular senescence in cancer: Unveiling dual roles, tumor microenvironment dynamics and therapeutic innovations (Review)

Organization linked by OpenAIRE · Shanghai University of Traditional Chinese Medicine

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

Cellular senescence in cancer: Unveiling dual roles, tumor microenvironment dynamics and therapeutic innovations (Review)

Organization linked by OpenAIRE · Tongji University

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

Cellular senescence in cancer: Unveiling dual roles, tumor microenvironment dynamics and therapeutic innovations (Review)

Organization linked by OpenAIRE · Central Hospital of Putuo District

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

From Lifespan Inequality to Lifespan Inequity

Organization linked by OpenAIRE · National Institute of Health

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

From Lifespan Inequality to Lifespan Inequity

Organization linked by OpenAIRE · National Institutes of Health

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

From Lifespan Inequality to Lifespan Inequity

Organization linked by OpenAIRE · Max Planck Society

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

From Lifespan Inequality to Lifespan Inequity

Organization linked by OpenAIRE · Max Planck Institute for Demographic Research

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

From Lifespan Inequality to Lifespan Inequity

Organization linked by OpenAIRE · Austrian Academy of Sciences

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

From Lifespan Inequality to Lifespan Inequity

Organization linked by OpenAIRE · Tel Aviv University

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

From Lifespan Inequality to Lifespan Inequity

Organization linked by OpenAIRE · Vienna Institute of Demography

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

From Lifespan Inequality to Lifespan Inequity

Organization linked by OpenAIRE · Johannes Kepler University of Linz

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
Research ↔ organizationOctober 14, 2025

From Lifespan Inequality to Lifespan Inequity

Organization linked by OpenAIRE · MEDIZINISCHE UNIVERSITAT GRAZ

An organization relationship stated by OpenAIRE, identified by ROR. This is not an institutional ranking.

Source: OpenAIRE Graph, CC BY 4.0. Fields selected and filtered by immortal.life; no endorsement implied. Licence

Inspect the source record →
FDA application actionOctober 14, 2025

liraglutide

Approved submission · SUPPL 26

A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.

Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence

Inspect the source record →
FDA application actionOctober 14, 2025

liraglutide

Approved submission · SUPPL 46

A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.

Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence

Inspect the source record →
FDA application actionOctober 14, 2025

liraglutide

Approved submission · SUPPL 22

A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.

Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence

Inspect the source record →
FDA application actionOctober 14, 2025

semaglutide

Approved submission · SUPPL 35

A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.

Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence

Inspect the source record →
FDA application actionOctober 14, 2025

semaglutide

Approved submission · SUPPL 37

A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.

Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence

Inspect the source record →
FDA application actionOctober 14, 2025

semaglutide

Approved submission · SUPPL 26

A dated action on a US drug application. It does not establish approval for longevity or describe the approved indication.

Data provided by the U.S. Food and Drug Administration through openFDA, CC0. Not a medical decision tool or approval for longevity. Licence

Inspect the source record →